Lv71
3280 积分 2023-08-22 加入
Rapid‐Turnaround Co‐Administration of mRNA‐Based MHC‐I and MHC‐II‐Restricted Neoantigens Enhances Immune Responses of Antigen‐Specific CD8+ T Cells and Anti‐Cancer Efficacy in Colorectal Cancer
20天前
已完结
Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy
20天前
已完结
An FDA oncology analysis of CD3 bispecific constructs and first-in-human dose selection
1个月前
已完结
Development of bispecific antibodies in China: overview and prospects
1个月前
已完结
‘Knobs-into-holes’ engineering of antibody CH3 domains for heavy chain heterodimerization
1个月前
已完结
Rejuvenation of tumour-specific T cells through bispecific antibodies targeting PD-L1 on dendritic cells
1个月前
已完结
Bispecific Antibody PD-L1 x CD3 Boosts the Anti-Tumor Potency of the Expanded Vγ2Vδ2 T Cells
1个月前
已完结
The role of PD-1/PD-L1 and application of immune-checkpoint inhibitors in human cancers
1个月前
已完结
Tebentafusp: a first-in-class treatment for metastatic uveal melanoma
2个月前
已完结
Tebentafusp: T Cell Redirection for the Treatment of Metastatic Uveal Melanoma
2个月前
已完结
皖公网安备34019202002308
